Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...
If you’ve received the COVID-19 vaccine, you may have experienced common side effects such as pain, fatigue, or fever, or ...